Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BNY vs GSK✓SelectedUSD · GSKBNY vs GSK performance historyLatest closeAs of-2.48%11/20
Stock and ETF performance explorer

BNY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+6,897.8%
GSK return
+1,644.3%
Excess return
+5,253.5%
Maximum drawdown
-64.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.5%-0.1%-2.4%-2.4%
7D-7.9%-5.3%-2.6%-5.8%
30D-2.7%-3.7%+0.9%-1.4%
3M-9.8%-7.3%-2.5%-7.3%
6M+3.8%-4.2%+8.1%+4.8%
YTD+23.8%+0.9%+23.0%+21.4%
1Y+35.0%+7.3%+27.7%+28.9%
3Y+220.9%+52.7%+168.1%+154.4%
5Y+183.3%+40.1%+143.2%+129.0%
10Y+284.5%+98.7%+185.8%+161.9%
All+6,897.8%+1,644.3%+5,253.5%+2,377.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling